| INSPIRE MEDICAL SYSTEMS |
| USA |
| Gesundheit |
| US4577301090 / A2JLEP |
| 2DR (Frankfurt) / INSP (NYSE) |
| FRA:2DR, ETR:2DR, 2DR:GR, NYSE:INSP |
| - |
| https://www.inspiresleep... |
|
Inspire Medical Systems, Inc. is a pioneering company focused on developing and commercializing innovative medical technology designed to treat obstructive sleep apnea (OSA). The company's flagship product, the Inspire therapy, is an implantable neur..
>Volltext.. |
| 1246.09 Mio. EUR |
| 1013.09 Mio. EUR |
| 788.53 Mio. EUR |
| 56.12 Mio. EUR |
| 125.74 Mio. EUR |
| 4.34 EUR |
| 27.8 Mio. EUR |
| 90.62 Mio. EUR |
| 101.14 Mio. EUR |
| 3.21 |
| 0.13% |
| 139.54% |
| - |
| - |
| - |
| - |
| INSPIRE MEDICAL |
| 01.04.26 |
|
||||
|